NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
9 hedge funds and large institutions have $253K invested in NeuroMetrix, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
150% more capital invested
Capital invested by funds: $101K → $253K (+$152K)
29% more funds holding
Funds holding: 7 → 9 (+2)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$82.6K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$27.5K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.4K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$16 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
-$59K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$6.75K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $127K | +$82.6K | +5,032 | New |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $50K | – | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| $42K | +$27.5K | +1,674 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $21K | +$10.4K | +635 | +347% |
|
|
5
UBS Group
Zurich,
Switzerland
| $8K | -$6.75K | -411 | -57% |
|
6
BlackRock
New York
| $5K | – | – | – |
|
|
WS
7
Wedbush Securities
Los Angeles,
California
| – | -$59K | -4,355 | Closed |
|
|
8
Fidelity Investments
Boston,
Massachusetts
| – | +$16 | +1 | New |
|
NURO Hedge Fund Activity: Q4 2020 in Review
9 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q4 2020, worth a combined $253K — up 150% from $101K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NURO positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $82.6K. The largest seller was Wedbush Securities, exiting entirely with an estimated $59K sold.
- 9 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q4 2020, up from 7 in Q3 2020.
- Funds reported $253K of NeuroMetrix, Inc. Common Stock stock for Q4 2020, up 150% quarter-over-quarter.
- 3 funds opened new NeuroMetrix, Inc. Common Stock positions in Q4 2020 and 1 closed out, a net change of +2 holders.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q4 2020 was Virtu Financial, an estimated $82.6K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q4 2020 was Wedbush Securities, an estimated $59K sold.
Based on aggregated 13F filings for Q4 2020.